Roche launches new ProGRP test for more precise diagnosis in lung cancer

New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu. Roche today announced the global launch (except US) of Elecsys ProGRP, a test that distinguishes between the two main types of lung cancer – small cell (SCLC) and non-small cell (NSCLC) lung cancer – and can help diagnose early-stage SCLC.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news